Intevac (IVAC)
NASDAQ:IVAC
Holding IVAC?
Track your performance easily

Intevac (IVAC) Income Statement

227 Followers

Intevac Income Statement

Last quarter (Q2 2024), Intevac's total revenue was $14.53M, an increase of 41.02% from the same quarter last year. In Q2, Intevac's net income was $-3.26M. See Intevac’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 54.98M$ 52.66M$ 35.76M$ 38.52M$ 52.13M$ 108.89M
Cost of Revenue
$ 32.29M$ 32.44M$ 20.68M$ 31.46M$ 29.71M$ 68.02M
Gross Profit
$ 22.69M$ 20.23M$ 15.09M$ 7.07M$ 22.42M$ 40.87M
Operating Expense
$ 33.74M$ 33.47M$ 31.60M$ 29.54M$ 2.80M$ 36.94M
Operating Income
$ -11.05M$ -13.24M$ -16.51M$ -22.48M$ 52.13M$ 3.92M
Net Non Operating Interest Income Expense
$ 5.49M$ 2.51M$ 1.24M$ 29.00K$ 284.00K$ 574.00K
Other Income Expense
$ -183.00K$ -53.00K$ -155.00K$ 35.00K$ 621.00K$ -8.00K
Pretax Income
$ -6.94M$ -10.79M$ -15.43M$ -22.48M$ -8.72M$ 4.51M
Tax Provision
$ 2.55M$ 1.82M$ 1.33M$ 575.00K$ 1.71M$ 3.36M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -8.29M$ -12.19M$ -17.07M$ 26.62M$ 50.42M$ 1.15M
Basic EPS
$ -0.31$ -0.47$ -1.36$ 2.18$ 0.04$ 0.05
Diluted EPS
$ -0.31$ -0.47$ -1.36$ 2.18$ 0.04$ 0.05
Basic Average Shares
$ 106.04K$ 26.12K$ 25.19K$ 24.35M$ 23.67M$ 23.06M
Diluted Average Shares
$ 106.04K$ 26.12K$ 25.19K$ 24.35K$ 24.15M$ 23.34M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 66.03M$ 65.91M$ 52.27M$ 61.00M$ 2.80M$ 104.96M
Net Income From Continuing And Discontinued Operation
$ -8.29M$ -12.19M$ -17.07M$ 26.62M$ 1.06M$ 1.15M
Normalized Income
$ 3.04M$ -52.52K-$ -16.20M--
Interest Expense
------
EBIT
$ -8.07M$ -13.24M$ -16.51M$ -22.48M$ -8.88M$ 4.51M
EBITDA
$ -6.21M$ -11.71M$ -15.02M$ -19.02M$ -5.40M$ 8.02M
Currency in USD

Intevac Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis